Endolymphatic sac tumour – a rare complication associated with von Hippel-Lindau disease

Czech version

Authors: Mária Wozniaková ^1,2; Vladimír Židlík ^1,2; Jozef Škarda ^1,2
Authors‘ workplace: Ústav klinické a molekulární patologie a lékařské genetiky, Oddělené klinické a molekulární patologie, Fakultní nemocnice Ostrava, Ostrava ¹; Ústav klinické a molekulární patologie a lékařské genetiky, Lékařská fakulta, Ostravská univerzita, Ostrava ²
Published in: Čes.-slov. Patol., 59, 2023, No. 1, p. 32-35
Category: Original Articles

Overview

We report the case of a 42-year – old female with familiar form von Hippel-Lindau disease (VHL) and recurrent endolymphatic sac tumour (ELST), which was presented like non-homogenous, solid and cystic expansion of the left petrous temporal bone. Histologically, there was found lamellae of bone with adjacent ligament and with papillary projections with fibrovascular core. The papillae were lined by a single layer of cuboidal epithelium with hyperchromatic and lightly pleomorphic nuclei. Sporadically, small cystic formations with eosinophilic, PAS positive secretion were noted. Imunohistochemically, the cuboidal cells showed diffuse positivity for vimentin, epithelial membrane antigen (EMA), cytokeratin AE1/AE3 and S100 protein (weakly). Other markers examined, including TTF1, PAX8 and CD10, were negative. Endolymphatic sac tumour is rare low-grade malignant epithelial tumour arising from the endolymphatic sac in the temporal bone, which occurs in 1 out of 30 000 births, with just fewer than 300 cases reported in the literature. About one third of cases are associated with von Hippel- Lindau disease, an autosomal dominant familial cancer syndrome.

Keywords:

temporal bone – endolymphatic sac tumour – von Hippel-Lindau disease

Sources

1. Hassard AD, Boudreau SF, Cron CC. Adenoma of the endolymphatic sac. J Otolaryngol 1984; 13: 213-216.

2. Heffner DK. Low-grade adenocarcinoma of probable endolymphatic sac origin. A clinicopathologic study of 20 cases. Cancer 1989; 64: 2292-2302.

3. Manski TJ, Heffner DK, Glenn GM, et al. Endolymphatic sac tumors: A source of morbid hearing loss in von Hippel-Lindau disease. JAMA 1997; 277: 1461-1466.

4. Mendenhall WM, Suárez C, Skálová A, et al. Current Treatment of Endolymphatic Sac Tumor of the Temporal Bone. Adv Ther 2018; 35: 887-898.

5. Wind JJ, Lonser RR. Management of von Hippel-Lindau disease-associated CNS lesions. Expert Rev Neurother 2011; 11(10): 1433-1441.

6. Varshney N, Kebede AA, Owusu-Dapaah H, Lather J, Kaushik M, Bhullar JS. A Review of Von Hippel-Lindau Syndrome. J Kidney Cancer VHL 2017; 4(3): 20-29.

7. Sun YH, Wen W, Wu JH, et al. Endolymphatic sac tumor: case report and review of the literature. Diagn Pathol 2012; 7: 36.

8. Eby TL, Makek MS, Fisch U. Adenomas of the temporal bone. Ann Otol Rhinol Laryngol 1988; 97: 605-612.

9. Malhotra S, Rao RV, Valiathan M, Mathew M, Nayak DR, Raja A. Low-grade adenocarcinoma of endolymphatic sac origin. Am J Otolaryngol 2006; 27: 362-365.

10. Yang X, Liu XS, Fang Y, Zhang XH, Zhang YK. Endolymphatic sac tumor with von Hippel- Lindau disease: report of a case with atypical pathology of endolymphatic sac tumor. Int J Clin Exp Pathol 2010; 7(5): 2609-2614.

11. Thompson LDR, Magliocca KR, Andreasen S, et al. CAIX and pax-8 Commonly Immunoreactive in Endolymphatic Sac Tumors: A Clinicopathologic Study of 26 Cases with Differential Considerations for Metastatic Renal Cell Carcinoma in von Hippel-Lindau Patients. Head Neck Pathol 2019; 13: 355-363.

12. Jester R, Znoyko I, Garnovskaya M, et al. Expression of renal cell markers and detection of 3p loss links endolymphatic sac tumor to renal cell carcinoma and warrants careful evaluation to avoid diagnostic pitfalls. Acta Neuropathologica Communications 2018; 6: 107.

13. Alkhotani A, Butt B, Khalid M, Binmahfoodh M, Al-Said Y. Endolymphatic sac tumor at the cerebellopontine angle: A case report and review of literature. Int J Surg Case Rep 2019; 58: 162-166.